Also on Trial Friend:Duchenne Muscular Dystrophy pageMatch Me
All 61 Duchenne Muscular Dystrophy trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMITMost sites in California, Florida and TexasRecruitingAges 2+Catalyst Pharmaceuticals31US sites
19 states - A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)Most sites in California, Arkansas and GeorgiaRecruitingPhase 1/2Ages 0-17Solid Biosciences12US sites
10 states - A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory CohortMost sites in California, Arkansas and FloridaRecruitingPhase 1Ages 2+Sarepta Therapeutics11US sites
8 states - Duchenne Electronic Health Record StudyMost sites in Utah, Arkansas and CaliforniaRecruitingThe Duchenne Registry11US sites
10 states - A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular DystrophyMost sites in Massachusetts, Arkansas and District of ColumbiaRecruitingAges 6+ITF Therapeutics9US sites
8 states - Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug TrialsMost sites in California, District of Columbia and IllinoisRecruitingVanderbilt University Medical Center9US sites
9 states - Biomarker Development for Muscular DystrophiesMost sites in Massachusetts, North Carolina and PennsylvaniaRecruitingAges 5+Massachusetts General Hospital4US sites
3 states - Once Weekly Infant Corticosteroid Trial for DMDMost sites in Ohio, Illinois and TexasRecruitingPhase 4Ages 1 Month-30 MonthsAnne M. Connolly4US sites
3 states - The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular DystrophyMost sites in New York and OhioRecruitingAges 0 Days-3University of Rochester4US sites
2 states - A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)Most sites in Arkansas, Texas and VirginiaRecruitingPhase 3Ages 7-11Solid Biosciences3US sites
3 states - Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular DisordersMost sites in California, Massachusetts and New YorkRecruitingAges 5+Columbia University3US sites
3 states - Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular DystrophyMost sites in Ohio and KansasRecruitingPhase 1Ages 18+Sardocor3US sites
2 states - Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability StudyMost sites in Georgia and IowaRecruitingPhase 2/3Ages 7+Italfarmaco2US sites
2 states - Magnetic Resonance Imaging and Biomarkers for Muscular DystrophyMost sites in Florida and OregonRecruitingAges 5-62University of Florida2US sites
2 states - PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)Most sites in Arkansas and MissouriRecruitingPhase 1/2Ages 2-7Precision BioSciences2US sites
2 states - Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing SettingMost sites in Tennessee and TexasRecruitingPhase 4Ages 4+Sarepta Therapeutics2US sites
2 states - DMD Voice: Qualitative Interviews With Patients and CaregiversOnly in PennsylvaniaRecruitingAges 10+Red Nucleus Enterprise Solutions1US site
- Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)Only in North CarolinaRecruitingPhase 3Ages 4-18Dyne Therapeutics1US site
- Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy PatientsOnly in FloridaRecruitingPhase 2Ages 6+University of Florida1US site
- Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular DystrophyOnly in TennesseeRecruitingPhase 1/2Ages 18+Vanderbilt University Medical Center1US site
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Duchenne Muscular Dystrophy trials in the US, and what stage they are in
Of the 27 Duchenne Muscular Dystrophy trials with a US site, 3 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 9 of them. Phase 4 studies of an already approved treatment make up 2. The remaining 13 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 11 of them, and universities, hospitals, foundations and government groups run 16. The sponsors with the most are Vanderbilt University Medical Center (4), University of Florida (3) and Sarepta Therapeutics (2). The most recently listed one first appeared on ClinicalTrials.gov on August 17, 2026.
Duchenne Muscular Dystrophy trials in the US, state by state
Of the 27 Duchenne Muscular Dystrophy trials with a US site, 24 accept children under 18. Their open sites are in 26 states and Washington, DC, most often Arkansas, North Carolina and California. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 17 states
US hospitals running the most Duchenne Muscular Dystrophy trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Duchenne Muscular Dystrophy.
- Arkansas Children's HospitalLittle Rock, Arkansas5 trials
- Vanderbilt University Medical CenterNashville, Tennessee5 trials
- Nationwide Children's HospitalColumbus, Ohio4 trials
- Seattle Children's HospitalSeattle, Washington4 trials
- Boston Children's HospitalBoston, Massachusetts3 trials
- Cincinnati Children's Hospital Medical CenterCincinnati, Ohio3 trials
- Stanford UniversityPalo Alto, California3 trials
- University of California, DavisSacramento, California3 trials
- University of FloridaGainesville, Florida3 trials
- Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Illinois2 trials
Help getting to a Duchenne Muscular Dystrophy trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Duchenne Muscular Dystrophy trial near you
Are there Duchenne Muscular Dystrophy clinical trials near me?
As of November 13, 2026, 61 Duchenne Muscular Dystrophy clinical trials are recruiting now and 16 are not yet recruiting. In the US, 27 of them have at least 1 open site, across 26 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Duchenne Muscular Dystrophy clinical trial sites?
Recruiting Duchenne Muscular Dystrophy trials list open sites in 26 states and Washington, DC. Arkansas, North Carolina and California have the most, and the table on this page lists every state.
Are there Duchenne Muscular Dystrophy trials for children near me?
Of the 27 Duchenne Muscular Dystrophy trials with a US site, 24 accept children under 18. Their open sites are in 26 states and Washington, DC, most often Arkansas, North Carolina and California. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Duchenne Muscular Dystrophy clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Duchenne Muscular Dystrophy trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Duchenne Muscular Dystrophy trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Duchenne Muscular Dystrophy: Agamree (vamorolone), Amondys 45 (casimersen), Duvyzat (givinostat), Elevidys (delandistrogene moxeparvovec), Emflaza (deflazacort), Exondys 51 (eteplirsen), Viltepso (viltolarsen), Vyondys 53 (golodirsen).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.